Bladder Wall Perfusion Pattern and Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms, and the Association of That Perfusion Pattern and Therapeutic Efficacy of Antimuscarinics for Female Overactive Bladder Syndrome.

Trial Profile

Bladder Wall Perfusion Pattern and Sexual Dysfunction in Female Patients With Lower Urinary Tract Symptoms, and the Association of That Perfusion Pattern and Therapeutic Efficacy of Antimuscarinics for Female Overactive Bladder Syndrome.

Recruiting
Phase of Trial: Phase III

Latest Information Update: 20 Sep 2016

At a glance

  • Drugs Tolterodine (Primary)
  • Indications Overactive bladder
  • Focus Therapeutic Use
  • Most Recent Events

    • 04 Sep 2016 Planned End Date changed from 1 Dec 2016 to 1 Dec 2017.
    • 04 Sep 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Jul 2017.
    • 06 Jul 2015 Planned End Date changed from 1 Dec 2014 to 1 Dec 2016 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top